CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- 4 Open-market buy CEO & Chairman bought 150,000 shares at $1.47 ($220,425)
- 4 Open-market buy CEO & Chairman bought 500,000 shares at $1.48 ($740,850)
- 4 Open-market buy CEO & Chairman bought 125,000 shares at $1.60 ($199,375)
- 4 Open-market buy CEO & Chairman bought 500,000 shares at $1.56 ($781,050)
- 4 Open-market buy CEO & Chairman bought 199,072 shares at $1.53 ($305,376)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at $1.59 ($159,000)
- 4/A Open-market buy CEO & Chairman bought 280,183 shares at $1.50 ($421,535)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at $1.62 ($161,980)
- 4 Open-market buy CEO & Chairman bought 280,183 shares at $1.50 ($421,535)
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 139,824 shares at an average $34.02 ($4,756,875)
- 4 Open-market sale 10% owner sold 84,774 shares at an average $34.19 ($2,898,314)
- 4 Open-market sale 10% owner sold 112,994 shares at an average $31.54 ($3,563,807)
- 4 Open-market sale 10% owner sold 88,839 shares at $33.50 ($2,976,346)
- 4 Open-market sale 10% owner sold 50,000 shares at $33.86 ($1,692,890)
- 4 Open-market sale 10% owner sold 135,000 shares at an average $33.78 ($4,560,363)
- 4 Grant or award CEO & Chairman acquired 500,000 shares (grant or award)
- 4 Grant or award Vice Chairman & CTO acquired 500,000 shares (grant or award)
Page 3 of 106 · 2,118 filings